Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death.
AQUEBOGUE, N.Y., July 15, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Prescription (RX) and Over-the-Counter (OTC) drug products and lots, within expiry, sold by OCuSOFT during the time period as indicated in the tables below. As a precautionary measure, Altaire is voluntarily initiating the recall due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility. The FDA has determined these issues indicate a lack of sterility assurance. Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death. This recall is being carried out to the RETAIL LEVEL and IS ONLY FOR THE SPECIFIC LOTS LISTED BELOW. No other lots are being recalled. A Retail Level recall is limited to product lots currently in inventory. Altaire further advises as follows: Product Description: OCuSOFT Homatropine Hydrobromide Ophthalmic Solution 5%
Product Description: OCuSOFT Tetcaine Hydrochloride Ophthalmic Solution USP, 0. 5%
Product Description: OCuSOFT Goniosoft Hypromellose 2.5% Ophthalmic Demulcent Solution
Product Description: OCuSOFT Tetravisc Forte
Product Description: OCuSOFT Tetravisc Forte
Product Description: OCuSOFT Tetravisc
Product Description: OCuSOFT Tetravisc
Product Description: OCuSOFT Flucaine
Product Description: OCuSOFT Eye Wash
Product Description: OCuSOFT Eye Wash
Product Description: OCuSOFT Tears Again Lubricant Eye Drops
Product Description: OCuSOFT Tears Again Lubricant Eye Drops
Product Description: OCuSOFT Tears Again Lubricant Eye Ointment Nighttime Relief
Product Description: OCuSOFT retaine NaCl Ophthalmic Ointment
Product Description: OCuSOFT retaine NaCl Ophthalmic Solution
The above products are labeled exclusively for OCuSOFT. Altaire ships the products labeled for OCuSOFT only to OCuSOFT. The products are distributed at the retail level by OCuSOFT. Altaire has also requested that OCuSOFT perform a subrecall. Altaire has notified OCuSOFT by e-mail on July 15, 2019 announcing the recalls of the products/lots identified herein, with specific directions for return of all units of the impacted lots. Any questions regarding this VOLUNTARY RECALL to the RETAIL LEVEL can be directed to Altaire Pharmaceuticals Inc., by calling 1-800-258-2471, or e-mailing otcdruggist@aol.com Monday thru Friday from 8:30 a.m. to 5:00 p.m. ET. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Altaire takes its mission of customer safety and providing quality products very seriously. The company is committed to, and diligently working to, ensure the sufficiency of Quality Assurance controls over critical systems in its manufacturing facility. Company Contacts:
View original content:http://www.prnewswire.com/news-releases/altaire-pharmaceuticals-inc-issues-voluntary-recall-of-multiple-ophthalmic-products-sold-by-ocusoft-300885261.html SOURCE Altaire Pharmaceuticals, Inc. |